Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Perks

Showing results (131-140 of 176) with videos related to

Pageof 18
Sort By:
Breast Cancer Research : BCR|August 21, 2004
p14ARF expression in invasive breast cancers and ductal carcinoma in situ--relationships to p53 and Hdm2S B Vestey, C Sen, C J Calder, et al.
Experimental Cell Research|July 2, 2013
Insulin-like growth factor binding protein-3 (IGFBP-3) plays a role in the anti-tumorigenic effects of 5-Aza-2'-deoxycytidine (AZA) in breast cancer cellsLi Zeng, Caroline Jarrett, Keith Brown, et al.
Experimental Dermatology|August 22, 2003
Role of the IGF-II receptor in mediating acute, non-genomic effects of retinoids and IGF-II on keratinocyte cell deathF Louafi, C E H Stewart, C M Perks, et al.
Endocrine-Related Cancer|October 19, 2016
Hyperglycaemia-induced resistance to Docetaxel is negated by metformin: a role for IGFBP-2K M Biernacka, R A Persad, A Bahl, et al.
BJU International|February 18, 2009
PTEN-mediated pathways and their association with treatment-resistant prostate cancerChristopher C Uzoh, Claire M Perks, Amit Bahl, et al.
Endocrine-Related Cancer|November 5, 2025
ERRATUM: Hyperglycaemia-induced resistance to Docetaxel is negated by metformin: a role for IGFBP-2K M Biernacka, R A Persad, A Bahl, et al.
Frontiers in Endocrinology|July 14, 2020
Mini Review: Opposing Pathologies in Cancer and Alzheimer's Disease: Does the PI3K/Akt Pathway Provide Clues?Rachel M Barker, Jeff M P Holly, Kalina M Biernacka, et al.
International Journal of Cancer|October 31, 2000
Insulin-like growth factor binding protein-3 (IGFBP-3) potentiates paclitaxel-induced apoptosis in human breast cancer cellsC A Fowler, C M Perks, P V Newcomb, et al.
Breast Cancer Research : BCR|January 12, 2005
Immunohistochemical expression of insulin-like growth factor binding protein-3 in invasive breast cancers and ductal carcinoma in situ: implications for clinicopathology and patient outcomeSarah B Vestey, Claire M Perks, Chandan Sen, et al.
Cancer Research|January 26, 2000
Increased p53-dependent apoptosis by the insulin-like growth factor binding protein IGFBP-3 in human colonic adenoma-derived cellsA C Williams, T J Collard, C M Perks, et al.
Pageof 18

Showing results (131-140 of 176) with videos related to

Sort By:
Pageof 18
Breast Cancer Research : BCR|August 21, 2004
p14ARF expression in invasive breast cancers and ductal carcinoma in situ--relationships to p53 and Hdm2S B Vestey, C Sen, C J Calder, et al.
Experimental Cell Research|July 2, 2013
Insulin-like growth factor binding protein-3 (IGFBP-3) plays a role in the anti-tumorigenic effects of 5-Aza-2'-deoxycytidine (AZA) in breast cancer cellsLi Zeng, Caroline Jarrett, Keith Brown, et al.
Experimental Dermatology|August 22, 2003
Role of the IGF-II receptor in mediating acute, non-genomic effects of retinoids and IGF-II on keratinocyte cell deathF Louafi, C E H Stewart, C M Perks, et al.
Endocrine-Related Cancer|October 19, 2016
Hyperglycaemia-induced resistance to Docetaxel is negated by metformin: a role for IGFBP-2K M Biernacka, R A Persad, A Bahl, et al.
BJU International|February 18, 2009
PTEN-mediated pathways and their association with treatment-resistant prostate cancerChristopher C Uzoh, Claire M Perks, Amit Bahl, et al.
Endocrine-Related Cancer|November 5, 2025
ERRATUM: Hyperglycaemia-induced resistance to Docetaxel is negated by metformin: a role for IGFBP-2K M Biernacka, R A Persad, A Bahl, et al.
Frontiers in Endocrinology|July 14, 2020
Mini Review: Opposing Pathologies in Cancer and Alzheimer's Disease: Does the PI3K/Akt Pathway Provide Clues?Rachel M Barker, Jeff M P Holly, Kalina M Biernacka, et al.
International Journal of Cancer|October 31, 2000
Insulin-like growth factor binding protein-3 (IGFBP-3) potentiates paclitaxel-induced apoptosis in human breast cancer cellsC A Fowler, C M Perks, P V Newcomb, et al.
Breast Cancer Research : BCR|January 12, 2005
Immunohistochemical expression of insulin-like growth factor binding protein-3 in invasive breast cancers and ductal carcinoma in situ: implications for clinicopathology and patient outcomeSarah B Vestey, Claire M Perks, Chandan Sen, et al.
Cancer Research|January 26, 2000
Increased p53-dependent apoptosis by the insulin-like growth factor binding protein IGFBP-3 in human colonic adenoma-derived cellsA C Williams, T J Collard, C M Perks, et al.
Pageof 18